Debut drug for Rett syndrome at edge of approval
The U.S. Food and Drug Administration plans to make an approval decision on the first-ever drug for girls and women with Rett syndrome by 12 March.
From funding decisions to scientific fraud, a wide range of societal factors shape autism research.
The U.S. Food and Drug Administration plans to make an approval decision on the first-ever drug for girls and women with Rett syndrome by 12 March.
Time is running out to expose this disreputable push for profit over care and change insurance, funding and training practices for the better.
This week, researchers on Twitter discussed false results in gene expression studies, a wearable neuron-recording device, and paper-publishing requirements.
Here is a roundup of news and research for the week of 20 February.
The “It Takes All Kinds of Minds” conference draws neurodiversity researchers, clinicians and community members to Scotland, where they plan to discuss interdisciplinary, transdiagnostic work.
After a year of intense growth, funding for biotech is in decline. The result is layoffs and program cuts — and maybe some innovation.
Tweets this week consider new research on how rare gene variants contribute to complex traits and microglia change their shape, plus views on diagnosing autism virtually.
Here is a roundup of news and research for the week of 13 February.
The COVID-19 pandemic forced a reckoning, in which autism clinicians had to redefine best practices and expand how children are evaluated. The remote assessments they developed may help solve a persistent problem: the long wait families endure to get a diagnosis in the United States.
Chung, a clinical and molecular geneticist, plans to continue serving as principal investigator of two large research projects involving cohorts of people with autism and related neurodevelopmental conditions.